With its new chair, Professor David Harrison, at the helm, CM-Path share top priorities

NCRI’s Cellular Molecular Pathology Initiative (CM-Path) was established in 2016 to bring together experts from pathology and other fields to build a stronger skills and resource base for the UK to undertake pathology research.

Professor David Harrison has recently been appointed to the CM-Path Chair position and a collaboration of NCRI Partners has committed £635,000 to the initiative to boost the UK’s research activity in cellular molecular pathology.

Looking forward to the next two years, David and CM-Path announce new aims alongside strategic plans to help make this transformative change in pathology and cancer research a reality in the UK.

» Read the full article on the CM-Path website